Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for Age-Related Hearing Loss
ChiCTR2500113713Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in presbycusis comparing coenzyme Q10 with Control: placebo (2 arms). Primary endpoint: Pure tone hearing threshold. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
coenzyme q10
03
Conditions
presbycusis
Beyond the preview
Go deeper on ChiCTR2500113713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113713.